https://www.nipro.co.jp/en/
Vision/Mission
Mission – Provide innovative and patient-oriented solutions for healthier lives.
Vision – To be a leading global healthcare company dedicated to developing and delivering high quality, innovative, total health care solutions.
Statement – Nipro Corporation is a leading global healthcare company dedicated to developing and delivering innovative and patient-oriented products for healthcare professionals, patients and the pharmaceutical industry. We are committed to positive patient outcomes and improvement in the quality of life around the world.
Business Description
Since its establishment in 1954, Nipro has expanded its business from glass materials to medical devices and pharmaceutical products, based on our corporate management philosophy and our concept of technological innovation. We provide products and technologies in a wide range of fields to meet the needs of patients and the medical treatment frontline.
The aim of Nipro now is to become a truly global comprehensive medical care company that can fulfill the desire of people of the world, having different cultures, customs and lifestyles, “to lead a healthy life”.
Our mission therefore is to strive earnestly to create new value from a “user-focused” unwavering attitude of how to contribute to medical services on a global scale.
Background
Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange.
Products/Services
Medical device, pharmaceutical and pharmapackaging businesses.
Markets
Japan, Thailand, China, Singapore, India, Bangladesh, Indonesia, UAE, Brazil, USA, Belgium, France, Germany, Switzerland.
Industry
Medical equipment.
Location
Head Office: 3-9-3 Honjo-nishi, Kita-ku, Osaka 531-8510, Japan
Telephone: +81-6-6372-2331
Facsimile: +81-6-6375-0669
http://www.nipro.co.jp/english/
Tokyo Office: 4-3-4 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
Telephone: +81-3-5684-5611
Facsimile: +81-3-5684-5610
Competitive Advantages
Nipro’s Strength—A “Trinity” Business Model
Medical devices, pharmaceuticals and glass products are the three pillars of Nipro’s business. We shall continue to further develop these business areas in a harmonious manner. Nipro’s unique strength of technology and know-how about medical devices, pharmaceuticals and glass products is manifested to the maximum extent, for instance, in our combination products like double bag kits and pre-filled syringes. Making full use of this strength would ensure safety of patients and labor saving in clinical practice. It would also enable speedy response to a wide range of emerging needs felt across the world and to seed ideas.
Financial Projection
Returning profits to shareholders is one of Nipro’s key business policies. The company aims for a dividend payout ratio of 40% over the medium and long term. For the fiscal year under review, Nipro paid a dividend of ¥32.50 per share, an increase of ¥2 per share compared with the previous fiscal year, for a payout ratio of 40.1%.
With objectivity a priority for its Board of Directors, Nipro proposed to increase the number of outside directors by one director, and nominated two female directors, at its general meeting of shareholders in June 2015.
As a long-term goal, Nipro targets sales of ¥500 billion by the fiscal year ending March 31, 2021, and is working toward this goal by reinforcing the competitiveness of its products as well as upgrading and expanding its lineup and sales networks.
As a goal even farther into the future, Nipro targets sales of ¥1 trillion by the fiscal year ending March 31, 2031, and is marshalling the entire group with the aim of becoming a global corporation.
Company Goals & Objectives
Nipro will coalesce its technological capabilities for the development of advanced products that contribute to extending life expectancies of people around the world by addressing the treatment, prevention, and examination needs of the medical treatment frontline. In order to meet the medical needs of all types of people, regardless of their culture, customs, lifestyles and age, around the world, Nipro aims to become a truly global comprehensive healthcare company that never fails to take the viewpoint of customers and patients. We sincerely appreciate the ceaseless support and encouragement of our shareholders as we pursue these goals.
Management
President: Yoshihiko Sano
Managing Directors: Makoto Sato, Kazuo Wakatsuki, Kiyotaka Yoshioka, Toshiaki Masuda, Kyoetsu Kobayashi
Employees
Parent company: 2,922
Consolidated subsidiaries: 20,231
Total: 23,153
